US2019241602A1PendingUtilityA1
Process for the preparation of macrolide antibacterial agents
Est. expiryOct 25, 2027(~1.3 yrs left)· nominal 20-yr term from priority
A61P 31/04C07H 17/08C07H 1/00
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Described herein are processes for the preparation of compounds of formula (I): and pharmaceutically acceptable salts, solvates, and hydrates thereof.
Claims
exact text as granted — not AI-modified1 . A process for preparing a compound of formula (I)
wherein
R 1 is a monosaccharide or polysaccharide;
A is —CH 2 —, —C(O)—, —C(O)O—, —C(O)NH—, —S(O)2-, —S(O)2NH—, —C(O)NHS(O)2-;
B is —(CH 2 ) n — where n is an integer ranging from 0-10, or B is an unsaturated carbon chain of 2-10 carbons, which may contain any alkenyl or alkynyl group;
C represents 1 or 2 substituents independently selected in each instance from the group consisting of hydrogen, halogen, hydroxy, alkyl, aralkyl, alkylaryl, alkoxy, heteroalkyl, aryl, heteroaryl, heteroarylalkyl, aminoaryl, alkylaminoaryl, acyl, acyloxy, sulfonyl, ureyl, and carbamoyl, each of which is optionally substituted;
V is —C(O)—, —C(═NR 11 )—, —CH(NR 12 R 13 )—, or —N(R 14 )CH 2 —; where R 11 is hydroxy or alkoxy, R 12 and R 13 are each independently selected from the group consisting of hydrogen, hydroxy, alkyl, aralkyl, alkylaryl, alkoxy, heteroalkyl, aryl, heteroaryl, heteroarylalkyl; dimethylaminoalkyl, acyl, sulfonyl, ureyl, and carbamoyl; R 14 is hydrogen, hydroxy, alkyl, aralkyl, alkylaryl, alkoxy, heteroalkyl, aryl, heteroaryl, heteroarylalkyl, dimethylaminoalkyl, acyl, sulfonyl, ureyl, or carbamoyl;
W is hydrogen, F, Cl, Br, I, or OH;
X is hydrogen; and Y is OW; where R 7 is hydrogen, a monosaccharide, a disaccharide, alkyl, aryl, heteroaryl, acyl, or —C(O)NR 8 R 9 , where R 8 and R 9 are each independently selected from hydrogen, hydroxy, alkyl, aralkyl, alkylaryl, heteroalkyl, aryl, heteroaryl, heteroarylalkyl, alkoxy, dimethylaminoalkyl, acyl, sulfonyl, ureyl, and carbamoyl; or X and Y taken together with the attached carbon to form C═O; and pharmaceutically acceptable salts, solvates, and hydrates thereof;
the process comprising the step of (a) reacting a compound of formula (IV)
wherein R 1 is a saccharide that includes a 2′-hydroxyl group, with a sterically hindered acylating agent R 1a -L, wherein R 1a is a sterically hindered acyl group and L is a leaving or activating group, to form the corresponding 2′-acyl derivative.
2 .- 23 . (canceled)Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.